Ignite Creation Date:
2024-05-05 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005999
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
2000-07-05
Brief Title:
Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
A Phase II Study of Arsenic Trioxide NSC 706363 in Patients With Advanced Cervical Carcinoma
Status:
COMPLETED
Status Verified Date:
2002-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
PURPOSE Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have stage IVB or recurrent cervical cancer
PURPOSE Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have stage IVB or recurrent cervical cancer
Detailed Description:
OBJECTIVES
Evaluate the efficacy of arsenic trioxide in patients with stage IVB or recurrent cervical carcinoma
Determine the safety of this treatment in these patients
OUTLINE Patients receive arsenic trioxide IV over 1-4 hours on days 1-5 Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 12-37 patients will be accrued for this study over 10-19 months
Evaluate the efficacy of arsenic trioxide in patients with stage IVB or recurrent cervical carcinoma
Determine the safety of this treatment in these patients
OUTLINE Patients receive arsenic trioxide IV over 1-4 hours on days 1-5 Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 12-37 patients will be accrued for this study over 10-19 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-30 | None | None | None |
| MSKCC-00018 | None | None | None |